These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4345101)

  • 1. Pharmacology of antagonists of angiotensin I and II.
    Needleman P; Johnson EM; Vine W; Flanigan E; Marshall GR
    Circ Res; 1972 Dec; 31(6):862-7. PubMed ID: 4345101
    [No Abstract]   [Full Text] [Related]  

  • 2. Angiotensin II. Synthesis and biological activity of 6-(1-methylhistidine) and 6-(3-methylhistidine) analogs.
    Needleman P; Marshall GR; Rivier J
    J Med Chem; 1973 Sep; 16(9):968-70. PubMed ID: 4355510
    [No Abstract]   [Full Text] [Related]  

  • 3. Antagonists of angiotensin. Effect on the blood pressure of normal and hypertensive rats.
    Saint-Louis J; Regoli D
    Rev Can Biol; 1972 Dec; 31(4):241-51. PubMed ID: 4350595
    [No Abstract]   [Full Text] [Related]  

  • 4. New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I.
    Paiva AC; Nouaihetas VL; Miyamoto ME; Mendes GB; Paiva TB
    J Med Chem; 1973 Jan; 16(1):6-9. PubMed ID: 4344926
    [No Abstract]   [Full Text] [Related]  

  • 5. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767
    [No Abstract]   [Full Text] [Related]  

  • 6. Angiotensin II antagonism. Structure-activity relationships of 8-substituted angiotensin II analogs.
    Fessler DC; Slipos F; Denning GS; Pals DT; Masucci FD
    J Med Chem; 1972 Oct; 15(10):1015-6. PubMed ID: 4341746
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin-like and antagonistic activities of N-terminal modified (8-leucine)angiotensin II peptides.
    Paiva TB; Goissis G; Juliano L; Miyamoto ME; Paiva AC
    J Med Chem; 1974 Feb; 17(2):239-41. PubMed ID: 4358432
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of angiotensin II antagonists in experimental hypertension.
    Bumpus FM; Smeby RR; Sweet C; Ferrario CM; Khosla MC
    Circ Res; 1973 May; 32():Suppl 1:150-8. PubMed ID: 4351356
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis of some analogs of angiotensin II as specific antagonists of the parent hormone.
    Khosla MC; Leese RA; Maloy WL; Ferreira AT; Smeby RR; Bumpus FM
    J Med Chem; 1972 Aug; 15(8):792-5. PubMed ID: 4339769
    [No Abstract]   [Full Text] [Related]  

  • 10. A carboxy-terminus truncated analogue of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists.
    Bovy PR; Trapani AJ; McMahon EG; Palomo M
    J Med Chem; 1989 Mar; 32(3):520-2. PubMed ID: 2918497
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative pharmacology of new specific angiotensin antagonists.
    Schoelkens BA
    Clin Sci Mol Med Suppl; 1975 Jun; 2():19s-21s. PubMed ID: 1077769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid-phase synthesis of (6-arginine)-, (4-histidine, 6-tyrosine)-, and (8-isoleucine)angiotensins II.
    Khosla MC; Kumar S; Smeby RR; Bumpus FM
    J Med Chem; 1972 Jun; 15(6):627-9. PubMed ID: 4337901
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of oxytocic and hypotensive activities of bradykinin by bradykinin-binding antibodies.
    Marin Grez M; Marin Grez MS; Peters G
    Eur J Pharmacol; 1974 Nov; 29(1):35-42. PubMed ID: 4373254
    [No Abstract]   [Full Text] [Related]  

  • 14. Alkylating analogs of peptide hormones. 2. Synthesis and properties of p-(N,N-bis(2-chloroethyl)amino)phenylbutyryl derivatives of angiotensin II.
    Paiva TB; Paiva AC; Freer RJ; Stewart JM
    J Med Chem; 1972 Jan; 15(1):6-8. PubMed ID: 4331919
    [No Abstract]   [Full Text] [Related]  

  • 15. Solid-phase synthesis of (3-proline,8-isoleucine)-,(1-sarcosine,3-proline,8-isoleucine)-, and (4-phenylalanine,8-isoleucine)angiotensin II as the antagonists of the parent hormone.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1973 Oct; 16(10):1184-5. PubMed ID: 4356140
    [No Abstract]   [Full Text] [Related]  

  • 16. Dose-response curves for angiotensin II and synthetic analogues in three types of smooth muscle: existence of different forms of receptor sites for angiotensin II.
    Papadimitriou A; Worcel M
    Br J Pharmacol; 1974 Feb; 50(2):291-7. PubMed ID: 4371902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of angiotensin II antagonists containing sarcosine in position 7.
    Moore GJ; Oudeman EM; Ko D; Nystrom DM
    J Med Chem; 1979 Sep; 22(9):1147-9. PubMed ID: 490564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent competitive antagonist of angiotensin II.
    Yamamoto M; Türker RK; Khairallah PA; Bumpus FM
    Eur J Pharmacol; 1972 May; 18(3):316-22. PubMed ID: 4338477
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of synthetic peptide on chronic renal hypertension in the rat.
    Loyke HF
    J Lab Clin Med; 1973 Sep; 82(3):406-11. PubMed ID: 4353878
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological observations on the hypotensive action of extracts of teleost fish Urophyses (urotensin I) in the rat.
    Lederis K; Medaković M
    Br J Pharmacol; 1974 Jul; 51(3):315-24. PubMed ID: 4375526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.